A study conducted by Platania et al. (50) demonstrated that oxytetracycline reduced the proliferative response of T lymphocytes through an in vivo model of autoimmune disease related to glucocorticoid-induced tumor necrosis factor receptor-related gene (GITR; TNFSRF18) in mice. This evidence concerns the gene TNFRSF18 and autoimmune disease.